Managing Patients Following a Negative Prostate Biopsy

February 2011
Renal & Urology News;Feb2011, Vol. 10 Issue 2, p23
The article addresses several issues affecting the scenario posed by patients who have undergone repeat biopsy for prostate cancer in the U.S. It stresses that urologists need to consider several factors when deciding a repeat biopsy which is more likely to indicate cancer because the previous tests missed its location. It also discusses the impact of high-grade prostatic intraepithelial neoplasia (HGPIN) on the likelihood of finding undiagnosed prostate cancer.


Related Articles

  • Perform a follow-up prostate biopsy even when the first is negative.  // Modern Medicine;Oct97, Vol. 65 Issue 10, p10 

    Focuses on the study recommending a second transrectal ultrasound-guided needle biopsy of the prostate when the first biopsy is negative. Target on men with high levels of prostate-specific antigen; Failure to identify small cancers during the first biopsy.

  • The effect of urologist experience on choosing active surveillance for prostate cancer. Chu, William; Kim, Brian; Slezak, Jeff; Harrison, Teresa; Gelfond, Joy; Jacobsen, Steven; Chien, Gary // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1701 

    Purpose: To evaluate the impact of the urologist's experience in selecting active surveillance (AS) versus immediate treatment (IT) for low-risk prostate cancer. Methods: Men with low-risk prostate cancer were enrolled from March 2011 to August 2013 at 13 medical centers in Kaiser Permanente...

  • An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? Feletto, E.; Bang, A.; Cole-Clark, D.; Chalasani, V.; Rasiah, K.; Smith, D. // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1677 

    Purpose: To compare prostate cancer incidence and mortality rates in Australia, USA, Canada and England and quantify the gap between observed prostate cancer deaths in Australia and expected deaths, using US mortality rates. Methods: Analysis of age-standardised prostate cancer incidence and...

  • Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results. Tewes, Susanne; Hueper, Katja; Hartung, Dagmar; Imkamp, Florian; Herrmann, Thomas; Weidemann, Juergen; Renckly, Stefan; Kuczyk, Markus; Wacker, Frank; Peters, Inga // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1707 

    Purpose: To evaluate a novel system for MRI/TRUS fusion-guided biopsy for detection of prostate cancer (PCa) in patients with previous negative prostate biopsy and determine diagnostic accuracy when using the Prostate Imaging Reporting and Data System (PI-RADS) for multiparametric magnetic...

  • Prostate screening: Some urologists are upset, others ambivalent about the new AAFP guidelines.  // Modern Medicine;Dec96, Vol. 64 Issue 12, p8 

    Presents excerpts from an article published in the November 1996 issue of `Urology Times,' stating the position of some urologists on the necessity of prostate cancer screening. American Academy of Family Physicians' recommendation of counseling for men about the known risks and uncertain...

  • PROSTATE CANCER DIAGNOSTICS WITH BIOPSY MATERIAL. Fedorina, T. A.; Poletaeva, S. V. // Saratov Journal of Medical Scientific Research / Saratovskii Nau;Oct-Dec2013, Vol. 9 Issue 4, p632 

    The aim of the article is to study the potential importance of specific location of biopsy of prostate cancer. Material and methods. Histological material from 700 patients has been examinated. 580 specimen of radical prostatectomy were examined. TRUS-guided 12-cores biopsy has been performed in...

  • Histopathological lesions in transrectal ultrasound guided biopsies of prostate in patients with raised serum prostate specific antigen: A preliminary report. Barakzai, Muhammed Abrar; Mubarak, Muhammed; Kazi, Javed Iqbal // Nephro-Urology Monthly;Jun2011, Vol. 3 Issue 3, p186 

    Background: Transrectal ultrasound (TRUS)-guided needle biopsies of prostate are considered the gold standard for the diagnosis of the prostatic cancer. Currently, there is no information on the spectrum of pathological lesions in TRUS biopsies of prostate in men from Pakistan. Objectives: To...

  • Urologic imaging for localized prostate cancer in 2007. Loch, Tillmann // World Journal of Urology;Apr2007, Vol. 25 Issue 2, p121 

    Increasing numbers of systematic random biopsies have virtually replaced urologic imaging as a detection and staging tool in prostate cancer. TRUS as the most commonly utilized urologic imaging is now mainly utilized to guide the biopsy needle into the correct anatomical or topographic region of...

  • A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center. Becker, Andreas; Seiler, Daniel; Kwiatkowski, Maciej; Kluth, Luis; Schnell, Dietrich; Graefen, Markus; Schlomm, Thorsten; Fisch, Margit; Recker, Franz; Weissbach, Lothar; Chun, Felix // World Journal of Urology;Aug2014, Vol. 32 Issue 4, p891 

    Objectives: To date, evidence on active surveillance (AS) is restricted to protocol-based studies. Conversely, practice patterns outside of such protocols are unknown. The aim of this study was to capture the current AS treatment patterns for localized prostate cancer in patients managed by...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics